Nine of the 56 genes in the region on 19q were described to be expressed in ovarian carcinoma in The Human Protein Atlas[36] (MARCH2, ANGPTL4, HNRNPM, ADAMTS10, NAPA, SLC1A5, CCDC8, CCDC9, BBC3 (PUMA)) and should receive extra attention when trying to identify candidate genes for harboring tumor suppressor mutations that could be associated with clinical outcome in further studies. This evidence concerns the gene MARCHF2 and ovarian carcinoma.